Risk factors for statin‐associated rhabdomyolysis
Pharmacoepidemiology and Drug Safety2006Vol. 16(3), pp. 352–358
Citations Over TimeTop 10% of 2006 papers
Stephanie D. Schech, David J. Graham, Judy A. Staffa, Susan E. Andrade, Lois La Grenade, Margaret Burgess, David K. Blough, Andy Stergachis, K. Arnold Chan, Richard Platt, Deborah Shatin
Abstract
Findings of this study indicate that older age is a risk factor for rhabdomyolysis among statin users. Although the evidence is not as strong, high statin dosage, renal disease, and female gender may be additional risk factors. Patients at higher risk of developing rhabdomyolysis should be closely monitored for signs and symptoms of the disease.
Related Papers
- → Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report(2009)99 cited
- → A case of rhabdomyolysis and tromboembolic event secondary to fibrate monotherapy(2008)9 cited
- → Rhabdomyolysis and Acute Renal Failure after Changing Statin-Fibrate Combinations(2000)31 cited